Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8881 - 8888 of 12092 results
Safe Harbor Negotiations Post-Paris
December 8, 2015| Blog| Viewpoint
Que Certa, Certa: Supreme Court Creates Uncertainty with "Cert" Review of Puerto Rico Recovery Act
December 8, 2015| Blog| Viewpoint
Determining Damages for Standard Essential Patents: the Federal Circuit Provides Some Guidance in CSIRO v. Cisco
December 7, 2015| Alert| Viewpoint
As Deadline for Expiration Approaches, Congressional Action Likely
December 7, 2015| Alert| Viewpoint
American Businesses Installing More Solar Than Ever
December 7, 2015| Blog| Viewpoint
The Continuing Conundrum of the California Food Fight
December 7, 2015| Blog| Viewpoint
Happy Holidays: VTech data breach affects over 11 million parents and children worldwide
December 7, 2015| Blog| Viewpoint
EB-5 Investors: Expect More Hassles Entering the United States
December 6, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|